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Microinjection of rat liver mRNA into Xenopus oocytes led to the synthesis of intracellular proalbumin and 
the secretion of mature albumin into the incubation medium. The ionophore monensin abolished the secre- 
tion of albumin but not the processing of the precursor. A variety of protease inhibitors were added to the 
incubation medium but there was no detectable inhibition of proalbumin cleavage. 
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1. INTRODUCTION 
A variety of eukaryote secreted proteins undergo 
post-translational proteolysis before release from 
the cell [1,2]. In many cases proteolytic leavage of 
the proform is obligatory for physiological activity 
[2,3]. The appearance of one or two basic residues 
at processing sites is common among proproteins 
[4,5] however, this feature alone does not con- 
stitute a signal for proteolysis and other structural 
and tissue specific markers must exist. 
Xenopus oocytes injected with exogenous 
mRNAs have been used as a surrogate system to 
investigate protein modifications and their effect 
on intracellular protein transport and secretion 
[6,7]. However, the limited ability of the oocyte to 
proteolytically cleave propeptide precursors may 
indicate not only the tissue specific nature of the 
signals but also the restricted distribution of the 
proteases involved [8,9]. To examine this 
phenomenon we have chosen to study the process- 
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ing of rat proalbumin in the oocyte. Serum 
albumin from several species exists as an in- 
tracellular proform, bearing an amino-terminal 
peptide which is proteolytically cleaved shortly 
before secretion [10]. Rat serum albumin (RSA) 
has a hexapeptide propiece with two arginine 
residues at the carboxy terminus [11,12]. We ex- 
amined the ability of the oocyte to proteolytically 
cleave the rat albumin precursor and the effect of 
monensin on the coupling of processing to secre- 
tion. We also report the effect of various protease 
inhibitors on the intracellular cleavage of rat pro- 
albumin. 
2. MATERIALS AND METHODS 
Female Wistar rats (100-150 g) were used for 
mRNA preparations. Oligo(dT) cellulose was from 
BRL Laboratories (Science Park, Cambridge); L- 
[35S]methionine (>800 Ci. mmo1-1) and Amplify 
were from Amersham International (Amersham, 
Bucks). The ionophore, monensin, and protease 
inhibitors, N-p-tosyl-L-lysyl-chloromethyl ketone 
(TLCK), leupeptin and diisopropyl fluorophos- 
phate (DFP), were supplied by Sigma (Poole, 
Dorset) as were all other analytical grade reagents. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 © 1987 Federation of European Biochemical Societies 75 
Volume 219, number 1 FEBS LETTERS July 1987 
Anti-rat serum albumin was raised in sheep 
(Wellcome Research). RSA and proRSA were 
prepared by the method of Quinn et al. [12]. 
Poly(A ÷) RNA was prepared as described [7] and 
stored under liquid nitrogen. Oocytes from 
Xenopus laevis were maintained in Barth's saline 
[6] and microinjected with RNA. Injected oocytes 
were incubated overnight at 21°C in Barth's saline 
with or without the appropriate inhibitor. Details 
of inhibitor concentrations are in the figure 
legends. Surviving oocytes were cultured in Barth's 
saline containing 0.7 mCi-m1-1 [35S]methionine 
with or without inhibitor for 6 h then transferred 
to unlabelled medium for 24 h. The time course ex- 
periment shown in fig.l involved the removal of 
batches of 5 labelled oocytes and their surrounding 
medium at the times described. Homogenisation 
and immunoprecipitation f oocyte extracts and 
incubation media with anti-rat serum albumin 
were done as described elsewhere [7]. Polyacryl- 
amide isoelectric focussing els were prepared by a 
modification of the method of Ames and Nikaido 
[13]. 607o slab gels were prepared (total volume 
30 ml) and polymerised by the addition of 1.4 ml 
of 0.14 mg. ml -~ riboflavin/2% TEMED. Poured 
gels were illuminated for 30 min using a photo- 
graphic light box at a distance of 5 cm. Polymeri- 
sation by this method was more reliable than the 
use of ammonium persulphate. RSA and proRSA 
were added as reference markers to each sample 
before isoelectric focussing. Gels were washed in 
10% acetic acid to remove ampholines then stained 
with Coomassie blue. Destained gels were prepared 
for fluorography using Amplify and following the 
manufacturers instructions. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the synthesis of rat albumin by 
oocytes injected with rat liver poly(A ÷) RNA. 
After 3 h labelling an intracellular species appears 
which cofocusses with rat proalbumin (track 1) but 
no labelled protein has been secreted (track 5). At 
later times in the incubation both albumin and pro- 
albumin appear in oocyte extracts (tracks 2 and 3) 
but only processed albumin is secreted (tracks 6 
and 7). I f  labelled oocytes are incubated in 
unlabelled medium for a further 16 h then most of 
the intracellular proalbumin disappears (track 4) 
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Fig.1. The synthesis and secretion of rat serum albumin 
in oocytes. Samples are derived from oocyte extracts 
(tracks 1-4) or incubation media (tracks 5-8) at the 
following times: 3 h (tracks 1 and 5), 5 h (tracks 2 and 
6), 8h (tracks 3 and 7) and after a 16h 'chase' in 
unlabelled medium (tracks 4 and 8). The migration of 
marker proalbumin and serum albumin are as indicated 
on the figure. 
and the secreted albumin band intensifies (track 8). 
It is clear from this experiment that the oocyte 
cleaves the basic hexapeptide from rat proalbumin 
and that this processing step is tightly coupled to 
secretion of the mature protein. 
Little is known about the mechanism which links 
proteolytic leavage to export and the associated 
intracellular proteases. We decided to investigate 
the phenomenon i  the oocyte using inhibitors of 
intracellular transport and proteolysis. The car- 
boxylic ionophore monensin inhibits the in- 
tracellular transport of secretory [14-16] and 
membrane [16,17] proteins. The presumed target 
of the ionophore is some element in the Golgi com- 
plex [18]. Fig.2 shows that in oocytes monensin in- 
hibits the secretion of rat albumin. In the control 
experiment half of the synthesised albumin was 
secreted from the oocytes (tracks 1 and 2). In other 
experiments >80% of the intracellular albumin 
was exported. These quantitative differences are 
probably caused by batch variation among oocytes 
so non-inhibitor controls are included in all ex- 
periments. 15/~M monensin completely inhibits 
albumin export (tracks 3 and 4) and small amounts 
of proalbumin accumulate in the oocyte. Increas- 
ing the monensin concentration (tracks 5 and 6) 
depresses ynthesis and causes the ratio of pro- 
albumin to albumin in the cell to increase. Monen- 
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Fig.2. The effect of monensin on proalbumin processing 
and secretion. Tracks 1, 3 and 5 are incubation media, 
tracks 2, 4 and 6 oocyte extracts. No inhibitor (tracks 1 
and 2), 15/zM monensin (tracks 3 and 4) and 30/~M 
monensin (tracks 5 and 6). Injected oocytes were 
incubated in Barth's saline containing the stated 
concentration of monensin for 2 h before incubation in 
[35S]methionine containing medium. The position of 
albumin and proalbumin is as indicated. 
sin did not produce the complete abolition of 
proalbumin processing seen in hepatocytes treated 
with the inhibitor [19,20]. The observed in- 
tracellular accumulation of albumin in the oocyte 
implies that the ability of monensin to block 
albumin secretion is not closely linked to inhibition 
of proteolytic processing. This may mean that pro- 
albumin is cleaved before it reaches the Golgi com- 
plex in oocytes, assuming that monensin acts on 
some Golgi element o block secretion. 
The specific protease(s) responsible for propro- 
tein cleavage have not been fully identified. It has 
been suggested that a membrane bound form of 
the enzyme cathepsin B is the convertase in rat liver 
[21]. We studied the effect of three protease in- 
hibitors on oocyte mediated processing of pro- 
albumin. Leupeptin and TLCK had no discernable 
effect on proalbumin conversion. Both inhibitors 
decreased activity of the rat liver processing en- 
zyme at concentrations below those used here [21]. 
Diisopropylfluorophosphate (DFP), a general in- 
hibitor of serine proteases, also failed to inhibit 
processing at 200/zM. We also examined the effect 
of DFP at 100/zM on isolated hepatocytes, but 
failed to find any inhibition of proalbumin pro- 
cessing (not shown). This concentration of DFP is 
enough to inhibit completely the cholinesterase ac- 
tivity of rat liver [22]. These results strongly sug- 
gest that in the oocyte, as well as in the rat 
hepatocyte, the converting enzyme is not a serine 
protease, a possibility that has been put forward 
for the propeptide convertase of human liver [23]. 
Our results show that Xenopus oocytes process 
rat proalbumin to a form minus the three arginine 
residues found in the propeptide, cleavage prob- 
ably occurs after the carboxy-terminal double 
arginine residues. However, it is clear that double 
basic residues are not always recognised as a signal 
for proteolysis in the oocyte. The frog cell also 
cleaves at a single arginine of pro-vasopressin but 
ignores the double basic residues between 
vasopressin and oxytocin found in the same 
molecule [24]. It may be that the intramolecular 
position of the cleavage signal is important since 
the oocyte also fails to convert proinsulin and 
secretes the intact precursor [25]. 
There may be two distinct levels of intracellular 
proteolysis. A general processing step catalysed by 
a protease common to a variety of different cell 
types, and a more tissue specific step involving en- 
zymes with a more restricted istribution. It is well 
known that the presence of certain proteases can 
determine the choice between alternative physio- 
logical signals. The proprotein neuropeptide 
precursors are cleaved at different sites depending 
on the cell type in which they are synthesised, thus 
the nature of the processing enzyme(s) in situ 
governs the type of neuropeptide secreted [26]. 
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